Journal Scan: Darbepoetin for treatment of anemia in cats with CKD
Erythropoiesis is largely controlled by the kidney's production of erythropoietin in response to anemia. In cats with chronic kidney disease, 30% to 65% have an associated anemia. The use of erythropoiesis-stimulating agents has been associated with a number of complications in cats, including a pure red cell aplasia, rendering patients transfusion-dependent. Darbepoetin is an effective erythropoiesis-stimulating agent in people, but there is little data on its use in companion animals.
What they did
What they found
Chalhoub S, Langston CE, Farrelly J. The use of darbepoetin to stimulate erythropoiesis in anemia of chronic kidney disease in cats: 25 cases. J Vet Intern Med 2012;26(2):363-369.
This “Journal Scan” was provided by Avi Blake, DVM, a freelance technical editor and writer in Eudora, Kan.